In order to control ever-increasing health care expenditure, Western and Asian countries are seeking to develop more efficient health care models. Studies on health care that focus specifically on Asian countries are rare, rendering this a unique and welcome addition to the literature. This book presents quantitative research on various aspects of health care reform and health policy in Asia-Pacific countries such as China, Indonesia, Japan, South Korea, Taiwan, and the US - nations diverse in their economic development, social demographic structure and health care expenditures. The book's main topic for discussion is the role of both government and health insurers in funding health care. The implementation of community-based, supplemental and national health insurance is explored, as are grants and the financing of hospitals and care for the elderly. The effectiveness of education as an input to health investment and the rehabilitation of patients are also examined. Aiming to close the gap between the existing economics research and the rapid pace of the development of Asian health care markets, this unique and timely book is a must read for policymakers, researchers, academics and students with a special interest in health economics, policies and services.

Currently developed countries pay much more attention to harmfully addictive substances than developing countries. However, the experience of developed countries is very relevant to the developing world since substance abuse is likely to impose a continually increasing burden of disease in this region in the near future. This book extends the frontiers of research on the economics of substance use and abuse in a variety of extremely significant ways. It focuses on the determinants and consequences of the consumption of cigarettes, alcohol, betel quid, and illicit drugs in the United States, Great Britain and Taiwan. The authors use a variety of empirical techniques to examine the roles of price, advertising, risk perception, time preference and forward-looking behaviour in consumption decisions and the effects of these decisions on labour market outcomes, unintended pregnancies and criminal violence. Economic Analysis of Substance Use and Abuse will be required reading for scholars of economic development and health economics.

This book uses an economic approach to analyze the socioeconomic causes and consequences of mental health disorders in China, with a special focus on mental depression. Based on a nationally representative dataset, we first investigate the prevalence and distribution of depression and depressive symptoms among China’s adult population, and then use several econometric methods to estimate the multi-dimensional disease burden of the mental disorder, such as its direct medical costs, its indirect economic costs, and its hidden costs on social trust and life satisfaction. In addition, we specifically address the socioeconomic determinants of mental health by examining how the relative and absolute economic status may determine people’s mental depression. Lastly, we propose an analytical framework to evaluate the four major hurdles that cause the treatment gaps of mental health care, and discuss the policy options to overcome such hurdles and to address the unmet mental healthcare needs in China and other developing countries. The book may facilitate our understanding on the complex determinants and implications of the rising prevalence of mental health disorders in developing countries like China. In addition to the students, teachers, and researchers in the fields of health economics and public health, the book may also be of interest to health policy makers and non-government agencies who are concerned with addressing the global mental healthcare challenges using economic policy tools.

The new edition of a textbook that combines economic concepts with empirical evidence, updated with material on the Affordable Care Act and other developments. This book introduces students to the growing research field of health economics. Rather than offer details about health systems without providing a theoretical context, Health Economics combines economic concepts with empirical evidence to enhance readers' economic understanding of how health care institutions and markets function. The theoretical and empirical approaches draw heavily on the general field of applied microeconomics, but the text moves from the individual and firm level to the market level to a macroeconomic view of the role of health and health care within the economy as a whole. The book takes a global perspective, with description and analysis of institutional features of health sectors in countries around the world. This second edition has been updated to include material on the U.S. Patient Protection and Affordable Care Act, material on the expansion of health insurance in Massachusetts, and an evaluation of Oregon's Medicaid expansion via lottery. The discussion of health care and health insurance in China has been substantially revised to reflect widespread changes there. Tables and figures have been updated with newly available data. Also new to this edition is a discussion of the health economics literature published between 2010 and 2015. The text includes readings, extensive references, review and discussion questions, and exercises. A student solutions manual offers solutions to selected exercises. Downloadable supplementary material is available for instructors.

The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.